Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 85712

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 22, 2020
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Teva Pharmaceuticals USA

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0971-02

D-1285-2020
Recall number
D-1285-2020
Initiated
May 22, 2020
Classification
Class II
Status
Terminated
Recalling firm
Teva Pharmaceuticals USA
Quantity
33,280 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Some bottles may contain mixed strengths of the product.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Some bottles may contain mixed strengths of the product.

Code information

Lot #: 42614718, Exp. date 02/2021

Distribution pattern

Nationwide within the United State and Puerto Rico.

drug · product 2 of 3

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0777-02

D-1286-2020
Recall number
D-1286-2020
Initiated
May 22, 2020
Classification
Class II
Status
Terminated
Recalling firm
Teva Pharmaceuticals USA
Quantity
41,348 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Some bottles may contain mixed strengths of the product.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Some bottles may contain mixed strengths of the product.

Code information

Lot #: 42617008, Exp. date 10/2021

Distribution pattern

Nationwide within the United State and Puerto Rico.

drug · product 3 of 3

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 20 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0973-02

D-1287-2020
Recall number
D-1287-2020
Initiated
May 22, 2020
Classification
Class II
Status
Terminated
Recalling firm
Teva Pharmaceuticals USA
Quantity
84,209 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Some bottles may contain mixed strengths of the product.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Some bottles may contain mixed strengths of the product.

Code information

Lot #: 42617891, exp. date 01/2022

Distribution pattern

Nationwide within the United State and Puerto Rico.

Field note

Send feedback

We'll only use this to respond to your feedback.